Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Capital Southwest
CSWC
$1.61B
| $254K | ﹤0.01% |
13,209
+2,945
| +29% | +$56.8K |
|
3277
Vanguard Industrials ETF
VIS
$8.15B
| $254K | ﹤0.01% |
+2,107
| New | +$279K |
|
|
Y
3278
DELISTED
Alleghany Corp
Y
| $254K | ﹤0.01% |
408
-37,525
| -99% | -$23.1M |
|
|
CALA
3279
DELISTED
Calithera Biosciences, Inc
CALA
| $254K | ﹤0.01% |
3,163
+389
| +14% | +$38.4K |
|
3280
Cytokinetics
CYTK
$10.7B
| $251K | ﹤0.01% |
39,704
-189,213
| -83% | -$1.39M |
|
3281
CALL
Micron Technology
MU
$1.03T
| $251K | ﹤0.01% |
+7,900
| New | +$299K |
|
|
PMO
3282
Franklin Municipal Opportunities Trust
PMO
$281M
| $251K | ﹤0.01% |
+22,321
| New | +$250K |
|
3283
XBiotech
XBIT
$70.4M
| $249K | ﹤0.01% |
49,036
-113,392
| -70% | -$465K |
|
|
GSKY
3284
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $249K | ﹤0.01% |
26,000
-523,151
| -95% | -$6.1M |
|
3285
Forte Biosciences
FBRX
$1.63B
| $248K | ﹤0.01% |
81
-143
| -64% | -$616K |
|
3286
Cracker Barrel
CBRL
$1.3B
| $247K | ﹤0.01% |
1,546
-63,928
| -98% | -$10.5M |
|
3287
FreightCar America
RAIL
$234M
| $247K | ﹤0.01% |
+36,963
| New | +$419K |
|
|
GBL
3288
DELISTED
GAMCO Investors, Inc.
GBL
| $247K | ﹤0.01% |
14,635
-6,968
| -32% | -$143K |
|
|
THR
3289
DELISTED
Thermon Group Holdings
THR
| $246K | ﹤0.01% |
12,126
-109,258
| -90% | -$2.46M |
|
3290
Coty
COTY
$2.46B
| $245K | ﹤0.01% |
37,322
-368,192
| -91% | -$3.4M |
|
3291
Green Dot
GDOT
$765M
| $245K | ﹤0.01% |
3,078
-241,211
| -99% | -$19.1M |
|
|
HQCL
3292
DELISTED
Hanwha Q CELLS Co., Ltd.
HQCL
| $245K | ﹤0.01% |
25,106
-38,734
| -61% | -$365K |
|
|
BLE
3293
DELISTED
BlackRock Municipal Income Trust II
BLE
| $244K | ﹤0.01% |
+18,900
| New | +$242K |
|
3294
Peapack-Gladstone Financial
PGC
$804M
| $244K | ﹤0.01% |
9,703
-118,416
| -92% | -$3.27M |
|
3295
Zillow
ZG
$8.53B
| $244K | ﹤0.01% |
7,767
-3,977
| -34% | -$140K |
|
|
HR
3296
DELISTED
Healthcare Realty Trust Incorporated
HR
| $244K | ﹤0.01% |
8,593
-10,873
| -56% | -$315K |
|
3297
Advanced Energy
AEIS
$11B
| $243K | ﹤0.01% |
5,670
+1,317
| +30% | +$58.7K |
|
|
VRTU
3298
DELISTED
Virtusa Corporation
VRTU
| $243K | ﹤0.01% |
5,700
-58,512
| -91% | -$2.67M |
|
|
ZNH
3299
DELISTED
China Southern Airlines Company Limited
ZNH
| $242K | ﹤0.01% |
+7,960
| New | +$244K |
|
3300
Rogers Communications
RCI
$19.7B
| $241K | ﹤0.01% |
4,700
-4,358
| -48% | -$226K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.